Rockwell Medical (NASDAQ: RMTI) reported Q4 EPS of $0.04, $0.04 better than the analyst estimate of $0.00. Revenue for the quarter came in at $24.7 million versus the consensus estimate of $24.07 million.

GUIDANCE:

Rockwell Medical sees FY2025 revenue of $65-70 million, versus the consensus of $83.19 million.

For earnings history and earnings-related data on Rockwell Medical (RMTI) click here.